XingSai Biotech has completed nearly 100 million yuan in Series A++ financing.

On January 19th, according to Kairui Capital, Qingdao Xingsai Biotechnology Co., Ltd. completed nearly 100 million yuan A++ round financing. This round of financing was jointly invested by Zhongke Yu Cheng Investment, Zhejiang Business Capital, and Shandong Caijin Capital, with Kairui Capital acting as the exclusive financial advisor.